← Eichor
Study identifier: NCT06047717 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Vision Loss Impact on Navigation in Virtual Reality

Condition: Stroke, Ischemic · Quadrantanopia · Hemianopsia, Homonymous  ·  Sponsor: University of Rochester

PhaseNA
Planned participants40
Who can joinAll sexes, 21 Years to 75 Years
Healthy volunteersYes

About this study

The purpose of this research is to better understand the impact of cortically-induced blindness (CB) and the compensatory strategies subjects with this condition may develop on naturalistic behaviors, specifically, driving. Using a novel Virtual Reality (VR) program, the researchers will gather data on steering behavior in a variety of simulated naturalistic environments. Through the combined use of computer vision, deep learning, and gaze-contingent manipulations of the visual field, this work will test the central hypothesis that changes to visually guided steering behaviors in CB are a consequence of changes to the visual sampling and processing of task-related motion information (i.e., optic flow).

This description comes directly from the study's public registry record.

Talk to the study team

Evan Burr  ·  585-275-5234  ·  Evan_Burr@URMC.Rochester.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of RochesterRochester, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06047717